DOI: 10.1093/CKJ/SFAB145 38
1 Patients without diabetes are also utilizing these drugs for weight loss when diet and exercise prove ineffective.1 Semaglutide, Ozempic, and Mounjaro are GLP-1 mimics that decrease blood glucose levels, change gastric emptying time, reduce cravings, and increase satiety.2-4 GLP-1 medications are prescribed as a once-weekly subcutaneous injection of 2.4-3.0 mg, depending on symptoms
GLP-1 receptor agonists shortage expected until 2025 Novo Nordisk the manufacturer of several GLP-1 receptor agonists such as liraglutide and semaglutide has said that it envisages intermittent supply shortages over the next 18 months, despite running factories 24/7 to increase production
"That doesn't mean the medications are necessarily causing these symptoms, but it could suggest that reports of menstrual changes and body temperature fluctuations are worth studying more systematically." Researchers Hope to Expand Beyond Reddit The team hopes the findings encourage scientists and healthcare providers to pay closer attention to the kinds of side effects patients are discussing online
The funding pipeline reinforces the same pattern
